On 20 February, 2025 Lawyerly reported Allergan may bring ‘state of the art’ defence in breast implants class action
William Roberts Lawyers is representing the class action in the case of Grace Mary Ruth Donnelly v Allergan Australia Pty Limited. They filed the action in the Federal Court on behalf of lead applicant Grace Donnelly, who underwent breast augmentation surgery in 2017 using Allergan 410 MF textured breast implants. The class action claims that Allergan did not comply with the Australian Consumer Law’s guarantee of acceptable quality and seeks compensation for loss and damage caused by the breach, group members’ costs, and damages for mental distress.
The implants were recalled in July 2019 by the Australian Therapeutic Goods Administration and Allergan after the US Food and Drug Administration reported higher occurrences of breast implant-associated anaplastic large cell lymphoma (BIA ALCL) in patients who received the textured implants. The class action alleges that recipients of the textured implants were significantly more likely to develop BIA ALCL due to a chronic inflammatory response caused by the implants
For more information and how to join the class action please click here
William Roberts Lawyers with the assistance of Omni Bridgeway Limited (formerly known as IMF Bentham) have brought proceedings against Allergan Inc, Allergan Limited and Allergan Australia Pty Ltd (collectively referred to in this website and related document as Allergan) on behalf of consumers who had a Natrelle Biocell macro-textured breast implant or Natrelle Biocell tissue expander (Defective Biocell Breast Implants) implanted in them in Australia on or after 1 January 2011 (Affected Consumers).
Affected Consumers are invited to sign up to the class action on the Omni Bridgeway website which can be found on this page.
